July 9, 2020 / 1:10 PM / a month ago

BRIEF-Fate Therapeutics Announces FDA Clearance Of Ind Application For First-Ever Ipsc-Derived Car T-Cell Therapy

Fate Therapeutics Inc:

* FATE THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR FIRST-EVER IPSC-DERIVED CAR T-CELL THERAPY

* FATE THERAPEUTICS INC - PHASE 1 CLINICAL STUDY WILL EVALUATE FT819 FOR PATIENTS WITH ADVANCED B-CELL LEUKEMIAS AND LYMPHOMAS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below